Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Combination Pills, Progesterone Pills, Others), By Distribution Channel (Retail Stores, Online Stores, Others), By Region and Competition, 2020-2030F

Market Overview

Global Emergency Contraceptive Pills Market was valued at USD 604.42 Million in 2024 and is expected to reach USD 779.70 Million in the forecast period with a CAGR of 4.31% through 2030. Emergency Contraceptive Pills (ECPs), often referred to as "morning-after pills" or day-after pills, are a form of contraception used to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. These pills are designed to be taken as soon as possible after unprotected sex and are not intended for regular or ongoing contraception. The primary purpose of ECPs is to reduce the risk of pregnancy when regular contraception methods fail, are not used, or were used incorrectly. They are not intended to terminate an established pregnancy, and they are not a form of abortion. ECPs are most effective when taken as soon as possible after unprotected sex. Their effectiveness decreases with time, so it's important to take them promptly. Some ECPs are effective up to 72 hours (3 days) after unprotected sex, while others may have a longer window of effectiveness, such as up to 120 hours (5 days). ECPs are generally considered safe for most people and are not associated with long-term health risks. However, like all medications, they may have potential side effects, which can include nausea, vomiting, breast tenderness, fatigue, and changes in menstrual patterns.

One of the primary drivers is the unmet need for contraception. Many individuals may not have access to or use regular contraception methods consistently, leading to a demand for emergency contraceptive options. Public awareness campaigns, educational initiatives, and improved sex education have contributed to a better understanding of emergency contraception, leading to increased use. The prevalence of unprotected sexual intercourse, whether due to contraceptive failure, lack of access to contraception, or other reasons, drives the demand for emergency contraception. In many countries, the availability of emergency contraceptive pills without a prescription has made them more accessible and has driven consumer demand. Changing lifestyles, including increased urbanization and a greater emphasis on career goals, can lead to situations where emergency contraception is needed. Concerns about sexually transmitted diseases (STDs) can lead to greater use of emergency contraception as a preventive measure after unprotected sex.

Key Market Drivers

High Incidence of Unprotected Sex

Emergency contraceptive pills (ECPs) are specifically designed to prevent unintended pregnancies when regular contraception methods have failed, were not used, or were used incorrectly. Unprotected sex carries a higher risk of pregnancy, and ECPs provide a timely and effective option to reduce this risk. Unprotected sex can result from a variety of circumstances, including contraceptive method failure (e.g., condom breakage), lack of access to contraception, sexual assault, or unexpected sexual encounters. In these emergency situations, individuals may turn to ECPs to prevent an unintended pregnancy. ECPs offer a level of privacy and discretion, allowing individuals to take control of their reproductive health without the need for a healthcare provider's involvement or the disclosure of personal information.

The effectiveness of ECPs decreases with time after unprotected sex. Therefore, individuals who engage in unprotected sex and want to prevent pregnancy are often motivated to obtain and use ECPs as soon as possible, making timeliness a crucial factor. In some cases, individuals may not have access to regular contraception methods, such as birth control pills or condoms. In these situations, ECPs can serve as a backup option to prevent pregnancy. Increasing awareness and education about emergency contraception have led to more people recognizing the availability and benefits of ECPs, which can drive demand. Changing lifestyles, including increased social activities and relationships, may lead to situations where individuals find themselves engaging in unprotected sex unexpectedly. Even when regular contraception methods are used correctly, there is always a small risk of failure. This concern can motivate individuals to use ECPs as an added precaution. In many countries, ECPs are legally available and may be accessible without a prescription. These regulatory factors can contribute to the demand for ECPs in cases of unprotected sex. For individuals who experience anxiety or worry after unprotected sex, the availability of ECPs can provide psychological relief and peace of mind. This factor will help in the development of the Global Emergency Contraceptive Pills Market.

In the United States, the use of emergency contraception has increased over time. According to data from the National Survey of Family Growth, the percentage of sexually experienced women aged 15–44 who have ever used emergency contraception rose from 4.2% in 2002 to 11% in 2006–2010. This upward trend reflects growing awareness and acceptance of ECPs as a viable option for preventing unintended pregnancies. Additionally, the World Health Organization (WHO) states that emergency contraception can prevent over 95% of pregnancies when taken within 5 days after intercourse, highlighting its effectiveness as a preventive measure. 

These statistics underscore the importance of timely access to ECPs and the role of education in promoting their use. As awareness continues to grow and access improves, the demand for emergency contraceptive pills is expected to rise, contributing to the expansion of the global market.

Increasing Unmet Need for Contraception

Inconsistent or non-use of regular contraception methods, such as birth control pills, condoms, or intrauterine devices (IUDs), significantly contributes to the risk of unintended pregnancies. Even with regular contraceptive use, failures can occur; for instance, condoms may break, or birth control pills might be missed. In such scenarios, individuals often turn to emergency contraceptive pills (ECPs) as a backup to prevent pregnancy.

Access to reliable contraception can be hindered by factors like geographical barriers, cost constraints, limited healthcare access, or cultural and social obstacles. ECPs offer a readily available option for those facing such challenges. Unplanned or unexpected sexual encounters, including instances of sexual assault or situations where contraception was unavailable, also lead individuals to seek ECPs to avert unintended pregnancies. The privacy and discretion ECPs provide empower individuals to manage their reproductive health without involving healthcare providers or disclosing personal information.

The effectiveness of ECPs diminishes with time after unprotected sex, prompting prompt use to reduce pregnancy risk. Increased awareness and education about emergency contraception have led to more individuals recognizing the availability and benefits of ECPs, driving demand among those with unmet contraceptive needs. Changing lifestyles, including increased social activities and relationships, may result in unexpected sexual activity without access to regular contraception. Even with correct use of regular contraception, a small risk of failure persists, motivating individuals to use ECPs as an added precaution.

In many countries, ECPs are legally available and may be accessible without a prescription, contributing to their demand among individuals with unmet contraception needs. For those experiencing anxiety about potential unintended pregnancies due to unmet contraception needs, the availability of ECPs offers psychological relief and peace of mind. These factors collectively accelerate the demand in the Global Emergency Contraceptive Pills Market.

According to the Centers for Disease Control and Prevention (CDC), unintended pregnancy rates in the United States declined by 15%, from 42.1 per 1,000 women aged 15–44 in 2010 to 35.7 in 2019. Despite this decline, a significant number of pregnancies remain unintended, underscoring the ongoing need for accessible emergency contraception options. Additionally, during 2022–2023, 3.7% of females aged 15–49 received emergency contraception, highlighting its role in addressing contraceptive needs. These statistics emphasize the critical role of ECPs in reproductive health strategies, particularly for individuals facing barriers to regular contraception or experiencing contraceptive failures.

Rising Awareness Emergency Contraception

As awareness of emergency contraception spreads, more individuals become cognizant of the availability of emergency contraceptive pills (ECPs) as a viable contraceptive option. 

Education and awareness campaigns often include information on how ECPs function to prevent pregnancy. Understanding the mechanism of action and the importance of timely administration ideally within 72 hours after unprotected intercourse enhances the likelihood of individuals seeking and using these pills when necessary. However, despite increased awareness, actual usage remains low; in 2019–21, only 0.49% of women reported ever using ECPs. 

Awareness efforts emphasize the time sensitivity of ECPs, informing individuals that these pills are most effective when taken promptly after unprotected intercourse, thereby motivating timely action. Additionally, such campaigns aim to dispel myths and misinformation about emergency contraception, leading to more accurate knowledge among potential users. For instance, among female college students in Chandigarh, only 7.3% had knowledge about ECPs, with a mere 14.7% aware of the correct timing for their use. 

Awareness campaigns often promote safe and responsible sexual behavior, including the use of regular contraceptive methods, while highlighting ECPs as a backup option in cases of contraceptive failure or unprotected sex. These efforts can also help reduce the stigma associated with emergency contraception, making it more socially acceptable to seek and use ECPs when necessary. Notably, awareness is higher among urban women (55%) compared to their rural counterparts (44%), indicating a need for targeted campaigns in rural areas. 

Increasing awareness extends to healthcare providers, enabling them to educate patients about emergency contraception. When healthcare professionals are well-informed, they can offer accurate information and guidance. However, studies have shown that even among medical students, awareness about ECPs is moderate, with only 60.2% having adequate knowledge, underscoring the need for enhanced educational programs. 

Awareness campaigns may coincide with efforts to improve access to ECPs, making them more readily available to consumers. In India, ECPs have been available over-the-counter since 2005, yet their usage remains low, with less than 1% of women reporting ever using ECPs as of 2015–16. 

Empowering individuals with knowledge about emergency contraception enables them to make informed decisions regarding their reproductive health. Public health initiatives that include awareness campaigns about sexual health and contraception can lead to increased awareness and use of ECPs as part of comprehensive family planning strategies. Advertising campaigns by pharmaceutical companies and healthcare organizations also play a significant role in raising awareness about ECPs. This multifaceted approach is essential to address the low usage rates and to ensure that individuals are informed and have access to emergency contraception when needed.

Download Free Sample Report

Key Market Challenges

Stigma and Misinformation

Stigma associated with emergency contraception can discourage individuals from seeking or using these pills. This stigma may arise from cultural, religious, or social beliefs that view emergency contraception as morally or socially unacceptable. There is often misinformation and myths surrounding emergency contraceptive pills, which can create confusion and hesitation among potential users. Common myths include misconceptions about their safety, effectiveness, and side effects. Stigma and misinformation can create barriers to accessing emergency contraception. For example, individuals may avoid seeking ECPs from healthcare providers or pharmacies due to fear of judgment or misunderstanding about how the pills work. Misinformation can contribute to a lack of awareness about emergency contraception. Some individuals may not even be aware that ECPs are available or how they can be obtained. The fear of being judged by healthcare providers, pharmacists, or peers can deter individuals from seeking emergency contraception. This fear may be based on the belief that using ECPs implies irresponsible behavior or promiscuity. Cultural and religious beliefs can strongly influence attitudes towards contraception, including emergency contraception. Some cultures and religious groups may consider the use of ECPs as morally unacceptable. Inadequate sexual education can contribute to misinformation about emergency contraception. Comprehensive sex education programs are essential in addressing this challenge and providing accurate information. Misinformation can lead to misconceptions about the side effects of emergency contraception, causing unnecessary concerns or fears about health risks.

Access and Equity

Access to healthcare services, including ECPs, can vary significantly by region. Rural areas and underserved communities may have limited access to pharmacies or healthcare providers, making it difficult for individuals in these areas to obtain ECPs promptly. The cost of ECPs can be a barrier to access for many individuals, especially in low-income or resource-constrained settings. Even when ECPs are available, their price can make them inaccessible to those with limited financial resources. In some regions, the healthcare infrastructure may be underdeveloped, leading to challenges in distribution and accessibility of ECPs. Limited availability of pharmacies, clinics, or trained healthcare providers can hinder access. Cultural norms, social attitudes, and stigma related to sexual and reproductive health can create barriers to accessing ECPs. In some cultures, discussing or seeking contraception may be discouraged or considered taboo. Individuals may be unaware of the existence of ECPs or how to obtain them, leading to underutilization even when they are available. In some regions, regulatory restrictions, age limits, or prescription requirements can limit access to ECPs. Changes in these regulations may be necessary to improve access and equity. In some cases, healthcare providers or pharmacists may have personal or religious objections to providing ECPs, leading to challenges in access for patients. Ensuring that adolescents have equitable access to ECPs is a particular concern, as they may face unique barriers related to consent, privacy, and stigma. Advocacy for lower prices and increased affordability of ECPs, particularly in low- and middle-income countries.

Key Market Trends

Telemedicine and E-Commerce

Telemedicine platforms have been providing individuals with the opportunity to consult with healthcare professionals remotely. This includes discussing their need for emergency contraception, receiving guidance on its use, and obtaining prescriptions when necessary. Telemedicine services have made it easier for individuals to access medical advice and prescriptions for emergency contraceptive pills from the comfort and privacy of their homes. Online retailers and e-commerce platforms have been offering emergency contraceptive pills for sale. This allows individuals to purchase these products discreetly and conveniently without visiting a physical pharmacy or healthcare provider. E-commerce platforms have expanded access to emergency contraception, especially for those who may feel uncomfortable or embarrassed discussing the topic in person. Depending on the region and local regulations, some e-commerce platforms may offer both prescription and non-prescription (over the counter) emergency contraceptive pills. This provides consumers with choices based on their specific needs and circumstances. Telemedicine and e-commerce provide a level of privacy and convenience that many individuals find appealing. They can access emergency contraception without face-to-face interactions and without disclosing their personal information to pharmacy staff or healthcare providers. Through telemedicine, individuals can engage in digital consultations with healthcare professionals who can assess their situation, provide guidance, and prescribe emergency contraception if deemed appropriate. This process may include video calls, chat services, or secure messaging. Telemedicine and e-commerce have the potential to expand access to emergency contraception to underserved areas or regions with limited access to healthcare facilities or pharmacies.

Segmental Insights

Type Insights

Based on the Type, Combination Pills emerged as the dominant segment in the Global Emergency Contraceptive Pills Market in 2024. Combination emergency contraceptive pills, which typically contain both progestin and estrogen hormones, are considered highly effective in preventing pregnancy when taken as directed. This effectiveness can make them a preferred choice for many consumers. Some combination pills have a longer window of efficacy compared to other forms of emergency contraception. This means they can be taken up to 72 hours or even 120 hours (depending on the specific product) after unprotected intercourse, providing a wider time frame for effectiveness. In some regions, combination emergency contraceptive pills are available both by prescription and over the counter (OTC). OTC availability enhances accessibility and convenience for consumers. Healthcare providers may recommend combination pills based on an individual's medical history and needs. This recommendation from healthcare professionals can drive the demand for combination emergency contraception.

Distribution Channel Insights

Based on the Distribution Channel, Retail Stores emerged as the dominant segment in the Global Emergency Contraceptive Pills Market in 2024. Retail stores, such as pharmacies and drugstores, are widely accessible to consumers in many regions. This accessibility makes it convenient for individuals to purchase emergency contraceptive pills when needed, often without the need for an appointment or prescription. In several countries, emergency contraceptive pills are available over the counter (OTC) without the need for a prescription. Retail stores are well-suited to distribute OTC products, further enhancing their market share. Retail stores offer a level of privacy and discretion for consumers. Many people prefer to purchase emergency contraception in person rather than through other channels, as it allows them to maintain their privacy. Retail stores typically provide immediate access to emergency contraceptive pills. This quick availability can be crucial, as these pills are most effective when taken as soon as possible after unprotected intercourse. Pharmacists and healthcare professionals working in retail stores can provide valuable information and guidance to customers regarding the proper use of emergency contraception.

Download Free Sample Report

Regional Insights

North America emerged as the dominant region in the Global Emergency Contraceptive Pills Market in 2024. North America, particularly the United States, has a large population and a high level of disposable income. This creates a substantial market for pharmaceutical products, including emergency contraceptive pills. The ability and willingness to pay for such products contribute to market dominance. The United States and Canada have regulatory environments that allow for relatively easy access to emergency contraceptive pills. In the United States, for example, emergency contraception has been available over the counter (OTC) without a prescription for some time, making it easily accessible to a broad range of consumers. North America boasts a well-developed healthcare infrastructure, including a network of pharmacies and healthcare providers. This infrastructure facilitates the distribution and accessibility of emergency contraceptive pills. There have been public health campaigns and educational efforts to raise awareness about emergency contraception in North America. These initiatives have contributed to increased knowledge and use of such products.

Recent Developments

• In August 2024, Marksans Pharma Limited announced that its wholly owned subsidiary, Relonchem Limited, received UK MHRA marketing authorization for Levonorgestrel 1.5 mg Tablets, an oral emergency contraceptive. Commonly known as the morning-after pill, it is a first-line option for preventing pregnancy when taken within 72 hours of unprotected intercourse or contraceptive failure.
• In May 2024, research revealed limited access to emergency contraceptive pills in Australia, with one-third of community pharmacies reporting they do not stock ulipristal acetate, a first-line option recommended by medical authorities. The findings highlight challenges in availability and accessibility of essential reproductive healthcare.
• In March 2024, Perrigo Company plc announced the nationwide rollout of Opill, the first FDA-approved over-the-counter daily birth control pill in the U.S. The product has been shipped to major retailers and pharmacies and will be available in stores and online later this month.
• In November 2023, Japan launched a trial for over-the-counter sales of emergency contraception at select pharmacies across all prefectures. Previously requiring a doctor’s prescription, the pills are now available at 145 pharmacies nationwide.

Key Market Players

• Afaxys Pharma LLC
• Bayer AG
• Combe Inc.
• Foundation Consumer Healthcare LLC
• Gedeon Richter Plc
• HLL Lifecare Ltd.
• Knoll Healthcare Pvt. Ltd.
• Laboratoire HRA Pharma SAS
• Lupin Ltd.
• Mankind Pharma Ltd.

 Report Scope:

In this report, the Global Emergency Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

•     Emergency Contraceptive Pills Market, By Type:

o   Combination Pills

o   Progesterone Pills

o   Others

•     Emergency Contraceptive Pills Market, By Distribution Channel:

o   Retail Stores

o   Online Stores

o   Others

• Emergency Contraceptive Pills Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Australia

§  Japan

o   Europe

§  Germany

§  France

§  United Kingdom

§  Spain

§  Italy

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Emergency Contraceptive Pills Market.

Available Customizations:

Global Emergency Contraceptive Pills Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Emergency Contraceptive Pills Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com